CAR-T（CAR-T）细胞疗法在非肿瘤性疾病中的应用
Chimeric antigen receptor T (CAR-T) cell therapy in non-oncological diseases.
CAR-T（CAR-T）细胞在血液系统恶性肿瘤中的应用推动了这种免疫治疗形式的显著进展。
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
接受 CAR-T 细胞治疗的淋巴瘤患者的支持治疗：高级实践提供者的视角
英文原题：Supportive Care for Patients with Lymphoma Undergoing CAR-T-cell Therapy: the Advanced Practice Provider's Perspective.
查看英文原题
Supportive Care for Patients with Lymphoma Undergoing CAR-T-cell Therapy: the Advanced Practice Provider's Perspective.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
研究思路按摘要原文分段
目的
本文的目的是描述接受细胞治疗的复发/难治性淋巴瘤患者的全方位支持性护理，重点关注高级实践提供者（APPs）的视角。
结果
CAR-T（CAR-T）细胞疗法在治疗复发/难治性B细胞血液系统恶性肿瘤方面已越来越可及，这要求对治疗期间可能出现的副作用、并发症和感染进行熟练且充分的处理。APPs通常在初次转诊时接触这些患者，并在整个CAR-T 细胞治疗过程中为其提供支持。随着APPs全面理解并掌握如何治疗、支持 and 引导B细胞恶性肿瘤患者完成CAR-T 细胞治疗，他们在这些患者的整个治疗过程中发挥着关键作用。支持治疗的标准化至关重要。
展开英文摘要原文
PURPOSE OF REVIEW: The purpose of our paper is to describe the all-encompassing supportive care for patients with relapsed or refractory lymphoma undergoing cellular therapy, with a focus on the advanced practice provider's (APPs) perspective. RECENT FINDINGS: Chimeric antigen receptor-T (CAR-T) cell therapy has become more available for treating relapsed or refractory B-cell hematologic malignancies, requiring proficient and adequate treatment of side effects, complications, and infections that may occur during therapy.
APPs often meet these patients during the initial referral and help to support them through the CAR-T cell therapy process. As APPs acquire a complete understanding and comprehensive knowledge of how to treat, support, and guide patients with B-cell malignancies through CAR-T cell therapy, they play a pivotal role in these patients throughout their treatment. Standardization of supportive care is paramount.
论文信息
- 作者
- Granroth G、Rosenthal A、McCallen M、Coughlin C、Benson H、Palmer J、Castro JE、Munoz J
- 单位
- Bone and Marrow Transplant, Mayo Clinic, 5777 E Mayo Blvd, Phoenix, AZ, USA. ginna.granroth@ctca-hope.com.United States
- 文献类型
- 综述
- 期刊
- Current oncology reports2022 Dec
- 原文标识
- PubMed 36336769 · DOI 10.1007/s11912-022-01330-z
在 PubMed 查看 → 出版商原文（DOI） 全文 PDF（PMC）· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →